Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer
Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. Despite advances in treatment, prognosis remains poor, necessitating the identification of reliable prognostic biomarkers. Costimulatory molecules (CMs) have shown to enhance antitumor immune res...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2024-09-01
|
| Schriftenreihe: | Heliyon |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2405844024128472 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|